Targeted mRNA Therapeutics for Treatment of Kidney Diseases

Time: 4:30 pm
day: Day One PM


  • Mercurna’s technology platform combines unique cell-targeting moieties, with a lipid-based delivery vehicle to deliver engineered mRNA with high specificity
  • Active targeting strategies through optimised technology on targeted LNPs
  • Showcasing examples on how Mercurna leverages its platform for development of targeted mRNA therapeutics to treat kidney diseases